Cargando…
Sterile, abscess-like cerebral lesion during trastuzumab therapy after HER2 status switch in a triple negative breast cancer patient: a case report and literature review
BACKGROUND: Breast cancer is a global health problem – it is the most common malignancy among women. Triple negative breast cancers (TNBC) account for 10–20% of female breast cancer. Most TNBC cases confer poor prognosis. Brain metastasis appears in more than 15% in the triple negative breast cancer...
Autores principales: | Mezei, Tamás, Hajdu, Melinda, Czigléczki, Gábor, Lotz, Gábor, Kocsis, Judit, Kulka, Janina, Horváth, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329406/ https://www.ncbi.nlm.nih.gov/pubmed/32611325 http://dx.doi.org/10.1186/s12885-020-07114-7 |
Ejemplares similares
-
Research on the predicting power of the revised Tokuhashi system: how much time can surgery give to patients with short life expectancy?
por: Mezei, Tamás, et al.
Publicado: (2020) -
Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer
por: Kocsmár, Ildikó, et al.
Publicado: (2022) -
Editorial: Guidelines From the Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kulka, Janina, et al.
Publicado: (2022) -
Safety survey on infusion reaction and cardiac dysfunction when switching from reference trastuzumab (HERCEPTIN(®)) to biosimilar trastuzumab (Trastuzumab‑NK) in the treatment of HER2‑positive breast cancer
por: Abe, Tomoya, et al.
Publicado: (2023) -
Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient
por: Lu, Nu T., et al.
Publicado: (2015)